Related Experiment Video

Updated: Jun 27, 2026

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
09:48

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance

Published on: February 17, 2023

A stress signaling pathway in adipose tissue regulates hepatic insulin resistance

Guadalupe Sabio1, Madhumita Das, Alfonso Mora

  • 1Howard Hughes Medical Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA.

Science (New York, N.Y.)
|December 6, 2008
PubMed

Insights

A high-fat diet activates c-Jun NH2-terminal kinase 1 (JNK1), causing insulin resistance. Targeting JNK1 in fat tissue may treat metabolic syndrome by preventing liver insulin resistance.

Area of Science:

  • Metabolic disease
  • Molecular biology
  • Endocrinology

Background:

  • High-fat diets activate c-Jun NH2-terminal kinase 1 (JNK1), a key regulator implicated in insulin resistance.
  • Insulin resistance is a core feature of metabolic syndrome, a cluster of conditions increasing the risk of heart disease, stroke, and type 2 diabetes.
  • JNK1 signaling in adipose tissue is a potential therapeutic target for metabolic disorders.

Purpose of the Study:

  • To investigate the specific role of adipose tissue JNK1 in diet-induced insulin resistance.
  • To elucidate the molecular mechanisms by which adipose JNK1 influences hepatic insulin sensitivity.

Main Methods:

  • Generation of genetically engineered mice with selective JNK1 gene ablation in adipose tissue.
  • Administration of a high-fat diet to assess diet-induced metabolic changes.
  • Analysis of insulin resistance markers, inflammatory cytokine expression, and key protein signaling pathways in liver and adipose tissue.

Main Results:

  • Selective JNK1 deficiency in adipose tissue significantly suppressed high-fat diet-induced insulin resistance in the liver.
  • JNK1 activation in adipose tissue promoted the secretion of interleukin-6 (IL-6).
  • Adipose-derived IL-6 led to increased expression of Suppressor of Cytokine Signaling 3 (SOCS3) in the liver, a known mediator of hepatic insulin resistance.

Conclusions:

  • JNK1 activation within adipose tissue is a critical driver of hepatic insulin resistance.
  • Targeting JNK1 signaling in adipose tissue represents a promising therapeutic strategy for combating metabolic syndrome and insulin resistance.

More Related Videos

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Hypothalamic-Pituitary Axis01:37

Hypothalamic-Pituitary Axis

The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...